Jump to ContentJump to Main Navigation
Health Care Regulation in AmericaComplexity, Confrontation, and Compromise$
Users without a subscription are not able to see the full content.

Robert I. Field

Print publication date: 2006

Print ISBN-13: 9780195159684

Published to Oxford Scholarship Online: September 2009

DOI: 10.1093/acprof:oso/9780195159684.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2019. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 16 October 2019

Regulation of Drugs and Health Care Products

Regulation of Drugs and Health Care Products

Chapter:
(p.114) 5 Regulation of Drugs and Health Care Products
Source:
Health Care Regulation in America
Author(s):

Robert I. Field

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780195159684.003.0005

This chapter reviews the regulation of drugs and products for safety and efficacy. It begins with a history of drug regulation, covering public health crises that engendered major expansions in 1906, 1938, and 1962. It then explains the oversight process for drugs and devices administered by the Food and Drug Administration (FDA) from clinical trials through post-market safety monitoring. More recent regulatory programs address a host of other issues. Several relate to marketing concerns, such as generic drug availability, off-label promotion, direct-to-consumer advertising, and reimportation of drugs at lower prices. Others address such disparate concerns as pediatric testing, access to experimental medications, and the safety of herbal supplements. The chapter also considers issues in food safety oversight, regulation of controlled substances, and drug coverage under Medicare Part D. It concludes by reviewing the policy debate over whether FDA strikes the right balance between assuring safety and availability of new drugs.

Keywords:   drugs, pharmaceuticals, prescriptions, medical devices, foods, generic drugs, patent, Food and Drug Administration

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .